Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization
about
Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathwayTRIB1 Is Regulated Post-Transcriptionally by Proteasomal and Non-Proteasomal Pathways.Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma.
P2860
Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bortezomib therapy-related lun ...... and clinical characterization
@ast
Bortezomib therapy-related lun ...... and clinical characterization
@en
type
label
Bortezomib therapy-related lun ...... and clinical characterization
@ast
Bortezomib therapy-related lun ...... and clinical characterization
@en
prefLabel
Bortezomib therapy-related lun ...... and clinical characterization
@ast
Bortezomib therapy-related lun ...... and clinical characterization
@en
P2093
P2860
P356
P1433
P1476
Bortezomib therapy-related lun ...... and clinical characterization
@en
P2093
Akihiko Gemma
Fumikazu Sakai
Harumi Y Mukai
Kazutake Yoshizawa
Kiyohiko Hatake
Makiko Miyao
Masahiko Kusumoto
Michiko Miyazawa
Shoji Kudoh
Takao Katoh
P2860
P304
P356
10.1111/CAS.12335
P577
2014-01-21T00:00:00Z